May 17, 2024
Focusing on the potential effects for medical cannabis patients, Americans for Safe Access held a high-level presentation and discussion on the rescheduling of cannabis.
Live from the Cannabis Science Conference, Julie Kowalski shares her perspective on the conference.
May 16, 2024
The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.
In this quick, onsite interview, Susan Audino shares the biggest development she saw from the Cannabis Science Conference Spring 2024.
May 15, 2024
In this quick, onsite interview, Program Chair of the Compliance Track, Kim Stuck, shares the biggest buzz from the Cannabis Science Conference Spring 2024.
May 14, 2024
At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.
May 10, 2024
In the Cultivation Track at Cannabis Science Conference, Bernie Lorenz, Chief Science Officer of ProKure Solutions, discussed the intriguing topic of the effects of COVID on cannabis testing methods.
In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.
May 09, 2024
Patrick Bird, Senior Manager of Scientific Affairs at bioMérieux, presented “Innovative Method Development to Meet the Needs for the Cannabis Industry" on the first day of Cannabis Science Conference in the Analytical Track.
As the keynote speaker for Cannabis Science Conference Spring 2024, Jamila Owens-Todd discussed the various ways to approach plant medicine and manufacturing.